The Centers for Medicare & Medicaid Services prepares to implement a historic financial adjustment affecting millions of ...

Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, including insulin for diabetes, and face no costs whatsoever for similar generic options under a ...